HDAC inhibition in glioblastoma monitored by hyperpolarized (13)C MRSI.

Vorinostat is a histone deacetylase (HDAC) inhibitor that inhibits cell proliferation and induces apoptosis in solid tumors and is in clinical trials for the treatment of glioblastoma (GBM). The goal of this study was to assess whether hyperpolarized (13)C Magnetic Resonance Spectroscopy (MRS) and M...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:NMR Biomed
Egile Nagusiak: Radoul, Marina, Najac, Chloé, Viswanath, Pavithra, Mukherjee, Joydeep, Kelly, Mark, Gillespie, Anne Marie, Chaumeil, Myriam M., Eriksson, Pia, Santos, Romelyn Delos, Pieper, Russell O., Ronen, Sabrina M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545173/
https://ncbi.nlm.nih.gov/pubmed/30561869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/nbm.4044
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak